Learn more on the topic of Varicella Zoster Virus (VZV) via our ongoing series of clinical posts by David Kilpatrick, PhD and Abbas Vafai, PhD.
INTRODUCTION: Relatively few multiplex lateral flow immunoassays (LFIAs) are available today for detecting viral pathogens, primarily due to technical and manufacturing hurdles. However, several of these assays are being developed. The detection of antibodies against more than one agent is probably the easiest type of multiplex assay to manufacture. The key components of such assays […]
INTRODUCTION: Lateral flow immunoassays (LFIAs) are an important component in point-of-care patient diagnostics. More LFIAs are being developed every year, driven by the need of rapid, low-cost information in a patient or hospital setting. Presented in this note will be the overall advantages and disadvantages to LFIAs, as well as new research to improve the […]
INTRODUCTION: In the last several years there has been an increasing demand for the development of infectious disease diagnostics which maintains test accuracy while reducing the time needed for detection at the point-of-care (POC) for the patient. Reducing the cost per assay as well as the equipment and end-user technical knowledge has been the driving […]